Ibrutinib
CAS 936563-96-1
Overview
Ibrutinib, sold under the brand name Imbruvica among others, is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase, that is important in B cells. It is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia
Anant Labs manufacture and furnish high quality Ibrutinib impurities for global markets. Our Ibrutinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
Cat. No.ANT-IBT-000
CAS936563-96-1
Mol. FormulaC25H24N6O2
Mol. Weight440.49 g/mol
IUPAC1-[3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
SMILESC=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N
InChIInChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)
InChI KeyXYFPWWZEPKGCCK-UHFFFAOYSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
Ibrutinib R-Isomer936563-87-0PCI-32765 (Racemate)Ibrutinib RacematePCI-32765 RacemateIbrutinib (Racemate)IBRUTINIB IMPURITY 881-[3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-oneC25H24N6O2PCI-32765 (Ibrutinib)
